Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose Tolerance Test

Glucose Tolerance Impaired in Pregnancy Clinical Trial

Official title:

Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03623412
• Other study ID #: 0068-18
• Status: Not yet recruiting
• Phase: N/A
• Start date: August 15, 2018
• Est. completion date: September 30, 2019

Study information

• Verified date: August 2018
• Source: Clalit Health Services
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to offer a 75g postpartum glucose tolerance test to women with minor degrees of glucose intolerance and to assess if these women are significantly different from women who were diagnosed as GDM (Gestational Diabetes Mellitus)

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 600
• Est. completion date: September 30, 2019
• Est. primary completion date: September 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• healthy women (without pre-existing diabetes) who underwent an OGTT during pregnancy

Exclusion Criteria:

• pre-existing diabetes, or failed to perform the OGTT

Related Conditions & MeSH terms

• Glucose Intolerance
• Glucose Tolerance Impaired in Pregnancy

Intervention

Diagnostic Test:
• 75g oral glucose tolerance test
Women with one abnormal value in the OGTT during pregnancy (minor degree of glucose intolerance) will be offered a post-partum 75g GTT (Glucose Tolerance Test), similar to that offered to women with GDM
• 75g GTT
post-partum GTT

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Clalit Health Services

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Positive post-partum GTT results		6-12 weeks post partum